Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

363 Views

C4. Respiratory infections - viral

Poster Session: Respiratory Infections - Viral

(P-677) Title: Estimation of Respiratory Syncytial Virus-attributable Hospitalizations among Older Adults in Japan between 2015 and 2018: an Administrative Health Claims Database Analysis

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

MS

Masafumi Seki, MD, PhD

Saitama Medical University International Medical Center
Hidaka City, Saitama, Japan
Yasuhiro Kobayashi, MS

Medical affairs manager
Pfizer Japan
Shibuya-ku, Tokyo, Japan
EM

Estelle Meroc, DVM, MPH, PhD

Data Analyst, Epidemiologist
P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium
Leuven, Vlaams-Brabant, Belgium
TK

Takahiro Kitano, MRes

Pfizer Japan Inc.
Tokyo, Tokyo, Japan
AP

Aleksandra Polkowska-Kramek, n/a

P95
Leuven, Brabant Wallon, Belgium

Asuka Yoshida, PhD (she/her/hers)

Medical Affairs Scientist
Pfizer Japan Inc.
Tokyo, Tokyo, Japan

Caihua Liang, MD, PhD

Senior Director
Pfizer Inc
New York, New York, United States
RB

Robin Bruyndonckx, n/a

P95
Leuven, Brabant Wallon, Belgium
SM

Solomon Molalign Moges, n/a

P-95
KESSEL-LO (LEUVEN), Vlaams-Brabant, Belgium
EC

Eduardo Conde-Sousa, PhD

P95 Pharmacovigilance and Epidemiology, Leuven, Belgium
Porto, Porto, Portugal
CN

Charles Nuttens, n/a

Pfizer Inc
Paris, Ile-de-France, France
BG

Bradford D. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States
Elizabeth Begier, MD, M.P.H.

Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland